Lanxess Acquires PTAP Product Line

Lanxess has acquired the Nipacide PTAP product line from Clariant .The active ingredient p-tert-amylphenol (PTAP) complements the phenolic active ingredients portfolio of Lanxess' Material Protection Products (MPP) business unit. The parties have agreed not to disclose financial details of the transaction. Lanxess will market the active ingredient under the tradename Preventol PTAP. It can be used alone or in combination with ortho-phenylphenol (Preventol O extra) and chlorophen (Preventol BP), which are also marketed by MPP, in hospital, household, industrial and veterinary disinfectants.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.